Skip to content
  • Product
    • Alteco LPS Adsorber
    • FAQ
    • IFU
  • Endotoxin removal
  • Treatment
    • Clinical benefits
    • How to use
  • Case stories & studies
    • Case story: Bergamo, Italy
    • Case story: Wroclaw, Poland
    • Scientific report: Oulu University Hospital, Finland
    • Scientific report: Wroclaw, Poland
    • Scientific report: Caserta, Italy
    • List of studies & references
  • Resources
    • Webinars
    • Science database
  • News & events
  • Company
    • About us
    • Board
    • Team
    • Quality
    • Investor relations
    • Career
  • Contact
    • Contact us
    • Partners and distributors
    • New partnerships wanted
  • Downloads
  • Product
    • Alteco LPS Adsorber
    • FAQ
    • IFU
  • Endotoxin removal
  • Treatment
    • Clinical benefits
    • How to use
  • Case stories & studies
    • Case story: Bergamo, Italy
    • Case story: Wroclaw, Poland
    • Scientific report: Oulu University Hospital, Finland
    • Scientific report: Wroclaw, Poland
    • Scientific report: Caserta, Italy
    • List of studies & references
  • Resources
    • Webinars
    • Science database
  • News & events
  • Company
    • About us
    • Board
    • Team
    • Quality
    • Investor relations
    • Career
  • Contact
    • Contact us
    • Partners and distributors
    • New partnerships wanted
  • Downloads

Subscribe

Online distributor training

Alteco Medical AB
Höstbruksvägen 8
SE-226 60 Lund
Sweden

+46 46 32 86 00 
info@altecomed.com

Serum lipopolysaccharides predict advanced liver disease in the general population

Serum lipopolysaccharides predict advanced liver disease in the general population

Endotoxin is associated with hospitalization, cancer or death related to liver disease in the general population.

MORE NEWS

Post navigation

Previous COVID-19 is adding to already burgeoning rates of sepsis, say experts

Post navigation

Next COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation

Alteco Medical AB • Höstbruksvägen 8 • SE-226 60 Lund • Sweden

T +46 46 32 86 00  •  info@altecomed.com

© 2025 Alteco Medical AB
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
ACCEPT ALL Reject Cookie settingsPrivacy policy
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT